newsfilter
← Latest News
GlobeNewswire·

LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29

BOCA RATON, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of